Condition
Trained Immunity
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 2 (1)
P 4 (2)
Trial Status
Completed3
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT05790499Not ApplicableCompleted
LDL-c Level Variability and Trained Immunity
NCT07772570Recruiting
Multimodal Biomarkers in Coronary Artery Disease Pathogenesis: The Oxford Acute Myocardial Infarction Study (OXAMI Study)
NCT05766345Phase 4Active Not RecruitingPrimary
BCG-induced Epigenetic Modifications in the NEXT Generation
NCT03400878Phase 4Completed
Comparing Morbidity and Mortality Effects of Two Different Strains of BCG
NCT02114255Phase 2Completed
Effects of BCG on Influenza Induced Immune Response
Showing all 5 trials